Table 5.
Metaregression analysis of Coagulase-negative Staphylococcus, Staphylococcus aureus, and E. coli in developing countries.
| Variable | Coefficient | P value |
|---|---|---|
| Coagulase-negative Staphylococcus | ||
| Years of study | -0.17 | 0.826 |
| Sample size | -0.23 | 0.983 |
| Brazil | -35.24 | 0.027 |
| Ethiopia | -70.95 | 0.002 |
| India | -61.44 | 0.000 |
| Jamaica | -59.55 | 0.001 |
| Jordan | -50.94 | 0.005 |
| Kenya | -79.15 | 0.001 |
| Mexico | -0.745 | 0.956 |
| Nepal | -48.54 | 0.005 |
| Nigeria | -67.75 | 0.002 |
| South Africa | -47.81 | 0.001 |
| Sudan | -76.75 | 0.001 |
| Tanzania | 59.23 | 0.004 |
| Zambia | -86.55 | 0.001 |
| Cross-sectional | 24.00 | 0.044 |
| Prospective | 1.45 | 0.813 |
| Staphylococcus aureus | ||
| Years of study | -0.48 | 0.483 |
| Sample size | -0.23 | 0.654 |
| Ethiopia | 49.42 | 0.134 |
| Gambia | 60.00 | 0.046 |
| Ghana | 22.20 | 0.472 |
| India | 18.84 | 0.406 |
| Indonesia | 9.74 | 0.758 |
| Nepal | 23.22 | 0.466 |
| Nigeria | 34.65 | 0.163 |
| Sudan | 21.30 | 0.437 |
| Tanzania | 18.62 | 0.558 |
| Uganda | 34.48 | 0.236 |
| Zambia | 14.62 | 0.644 |
| Cross-sectional | -21.72 | 0.149 |
| Prospective cohort | -9.50 | 0.445 |
| E. coli | ||
| Year of study | -0.6604672 | 0.556 |
| Sample size | 0.022806 | 0.401 |
| Bangladesh | 5.2 | 0.866 |
| Cameroon | 18 | 0.565 |
| Egypt | -0.5400002 | 0.986 |
| Ghana | 0.5999999 | 0.984 |
| India | 28.44278 | 0.273 |
| Nigeria | 1.998955 | 0.940 |
| Tanzania | 11.07911 | 0.679 |